Cory Bentley
Rady MBA '11
- Profile
Profile
Abintus Bio
- In vivo genetic medicine
- Founded: 2020
- Funding Raised: $9M
- Currently Operational
RIFT Biotherapeutics
- Addressing the mechanisms of cancer treatment resistance
- Founded: 2015
- Funding Raised: $9M
- Merged or Acquired in 2018 (New Company - Portage Biotech)
